期刊文献+

乳腺导管原位癌术后全身多脏器转移一例 被引量:2

原文传递
导出
摘要 乳腺导管原位癌(ductal carcinoma in situ,DCIS)属于非浸润性乳腺癌,病理形态学表现为乳腺导管上皮细胞癌变且局限于导管的基膜内,未侵犯间质,临床发病率约占乳腺癌的10%左右。
出处 《中华乳腺病杂志(电子版)》 CAS CSCD 2016年第4期249-251,共3页 Chinese Journal of Breast Disease(Electronic Edition)
基金 深圳市科技创新委员会项目(编号:JCYJ2013031200503931)
  • 相关文献

参考文献14

  • 1邵志敏,沈镇宙,徐兵河,主编.乳腺肿瘤学[M].上海:复旦大学出版社,2013: 24-25.
  • 2Cuzick J, Sestak I, Pindcr SE, et al. Effect of tamoxifen and radiotherapy in women with locally excised ductal carcinoma in situ: long-term results from the UK/ANZ DCIS trial [ J ]. Lancet Oncol,2011,12(1):21-29.
  • 3朱思吉,沈坤炜.乳腺导管内癌的外科治疗进展[J].中华医学杂志,2014,94(48):3865-3867. 被引量:3
  • 4Zavagno G, Carcoforo P, Marconato R, et al. Role of axillary sentinel lymph node biopsy in patients pure ductal carcinoma in situ of the breast[J]. BMC Cancer,2005,5:28.
  • 5Ko BS, Lim WS, Kim HI, et al. Risk factor for axillary lymph node metastases in microinvasive breast cancer[J]. Ann Surg Oncol, 2012, 19(1) :212-216.
  • 6Silver SA, Tavassoli FA. Mammary ductal carcinoma in situ with microinvasion. [J]. Cancer, 1998, 82(12) :2382-3290.
  • 7Smigal C, Jemal A, Ward E, et al. Trends in breast cancer by race and ethnicity: update 2006[J]. CA Cancer J Clin, 2006, 56(3) :168- 183.
  • 8Castellana B, Escuin D, Peir6 G, ct al. ASPN and GJB2 are implicated in the mechanisms of invasion of ductal breast carcinomas [J]. JCancer, 2012, 3:175-183.
  • 9Volinia S, Galasso M, Sana ME, et al. Breast cancer signatures for invasiveness and prognosis defined by deep sequencing of microRNA [J]. Proc Natl Acad Sci U S A, 2012, 109(8) :3024-3029.
  • 10Hughes LL, Wang M, Page DL, et al. Local excision alone without irradiation for ductal carcinoma in situ of the breast: a trial of the Eastern Cooperative Oncology Group[J]..I Clin Oncol,2009,27 (32) : 5319-5324.

二级参考文献38

  • 1张荣新,范江,王圣应,王磊,王朝夫,李同度.Survivin在乳腺癌组织中的表达及其临床意义[J].肿瘤防治杂志,2005,12(19):1476-1479. 被引量:4
  • 2Harris JR, Lippman ME, Veronesi U, et al. Breast cancer(2)[J].N EnglJ Med, 1992, 327(6): 390-398.
  • 3Burstein HJ, Polyak K, WongJS, et al. Ductal carcinoma in situ of the breast[J].N EnglJ Med, 2004, 350(14): 1430-1441.
  • 4Levine M. Cfinical practice guidelines for the care and treatment of breast cancer: adjuvant systemic therapy for node-negative breast cancer (summary of the 2001 update)[J]. CMAJ, 2001, 164(2): 213.
  • 5Solin LJ, Fourquet A, Vicini FA, et al. Salvage treatment for local re- currence after breast-conserving surgery and radiation as initial treatment for mammographically detected ductal carcinoma in situ of the breast[J]. Cancer, 2001, 91(6): 1090-1097.
  • 6The management of ductal carcinoma in situ(DCIS). The SteeringCommittee on Clinical Practice Guidelines for the Care and Treatment of Breast Cancer. Canadian Association of Radiation Oncologists[J]. CMAJ, 1998, 158 Suppl 3: $27-34.
  • 7HoughtonJ, George WD, GuzickJ, et al. Radiotherapy and tamoxifen in women with completely excised ductal carcinoma in situ of the breast in the UK, Australia, and New Zealand: randomised controlled triM[J].Lancet, 2003, 362(9378): 95-109.
  • 8Cuzick J, Sestak I, Pinder SE, et al. Effect of tamoxifen and radio- therapy in women with locally excised ductal carcinoma in situ: long-term results from the LrK/ANZ DCIS trial[J]. Lancet Oncol, 2011, 12(1): 21-29.
  • 9Fisher B, DignamJ, Wolmark N, et al. Lumpectomy and radiation therapy for the treatment of intraductal breast cancer: mdings from National Surgical Adjuvant Breast and Bowel Project B-17[J].J Clin Oncol, 1998, 16(2): 441-452.
  • 10Bijker N, Meijnen P, Peterse JL, et al. Breast-conserving treatment with or without radiotherapy in ductal carcinoma-in-sire: ten-year results of European Organisation for Research and Treatment of Cancer randomized phase Ill trial 10853-a study by the EORTC Breast Cancer Cooperative Group and EORTC Radiotherapy Group [J]. ] Clin Oncol, 2006, 24(21): 3381-3387.

共引文献64

同被引文献17

  • 1邵志敏,沈镇宙,徐兵河,主编.乳腺肿瘤学[M].上海:复旦大学出版社,2013: 24-25.
  • 2Cuzick J, Sestak I, Pindcr SE, et al. Effect of tamoxifen and radiotherapy in women with locally excised ductal carcinoma in situ: long-term results from the UK/ANZ DCIS trial [ J ]. Lancet Oncol,2011,12(1):21-29.
  • 3Zavagno G, Carcoforo P, Marconato R, et al. Role of axillary sentinel lymph node biopsy in patients pure ductal carcinoma in situ of the breast[J]. BMC Cancer,2005,5:28.
  • 4Ko BS, Lim WS, Kim HI, et al. Risk factor for axillary lymph node metastases in microinvasive breast cancer[J]. Ann Surg Oncol, 2012, 19(1) :212-216.
  • 5Silver SA, Tavassoli FA. Mammary ductal carcinoma in situ with microinvasion. [J]. Cancer, 1998, 82(12) :2382-3290.
  • 6Smigal C, Jemal A, Ward E, et al. Trends in breast cancer by race and ethnicity: update 2006[J]. CA Cancer J Clin, 2006, 56(3) :168- 183.
  • 7Castellana B, Escuin D, Peir6 G, ct al. ASPN and GJB2 are implicated in the mechanisms of invasion of ductal breast carcinomas [J]. JCancer, 2012, 3:175-183.
  • 8Volinia S, Galasso M, Sana ME, et al. Breast cancer signatures for invasiveness and prognosis defined by deep sequencing of microRNA [J]. Proc Natl Acad Sci U S A, 2012, 109(8) :3024-3029.
  • 9Hughes LL, Wang M, Page DL, et al. Local excision alone without irradiation for ductal carcinoma in situ of the breast: a trial of the Eastern Cooperative Oncology Group[J]..I Clin Oncol,2009,27 (32) : 5319-5324.
  • 10刘现军,金东岭,席丰,时志民.乳腺导管内癌中Ezrin和Survivin表达及临床病理意义[J].中国实验诊断学,2011,15(1):69-71. 被引量:6

引证文献2

二级引证文献2

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部